Terminal deoxynucleotidyl transferase and CD84 identify human multi-potent lymphoid progenitors.
YeEun KimAriel A CalderonPatricia FavaroDavid R GlassAlbert G TsaiDaniel HoLuciene BorgesWilliam J GreenleafSean C BendallPublished in: Nature communications (2024)
Lymphoid specification in human hematopoietic progenitors is not fully understood. To better associate lymphoid identity with protein-level cell features, we conduct a highly multiplexed single-cell proteomic screen on human bone marrow progenitors. This screen identifies terminal deoxynucleotidyl transferase (TdT), a specialized DNA polymerase intrinsic to VDJ recombination, broadly expressed within CD34 + progenitors prior to B/T cell emergence. While these TdT + cells coincide with granulocyte-monocyte progenitor (GMP) immunophenotype, their accessible chromatin regions show enrichment for lymphoid-associated transcription factor (TF) motifs. TdT expression on GMPs is inversely related to the SLAM family member CD84. Prospective isolation of CD84 lo GMPs demonstrates robust lymphoid potentials ex vivo, while still retaining significant myeloid differentiation capacity, akin to LMPPs. This multi-omic study identifies human bone marrow lymphoid-primed progenitors, further defining the lympho-myeloid axis in human hematopoiesis.
Keyphrases
- bone marrow
- endothelial cells
- single cell
- induced pluripotent stem cells
- pluripotent stem cells
- dendritic cells
- induced apoptosis
- mesenchymal stem cells
- acute myeloid leukemia
- high throughput
- escherichia coli
- poor prognosis
- genome wide
- cystic fibrosis
- pseudomonas aeruginosa
- binding protein
- cell proliferation
- immune response
- single molecule
- rna seq
- small molecule
- circulating tumor
- cell therapy